|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.912 SEK | -14.77% |
|
-0.87% | -31.17% |
Glycorex Transplantation AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 30.45 million compared to SEK 37.39 million a year ago. Revenue was SEK 33.4 million compared to SEK 39.33 million a year ago.
Net loss was SEK 30.36 million compared to SEK 8.58 million a year ago. Basic loss per share from continuing operations was SEK 0.41 compared to SEK 0.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.17% | 6.14M | |
| +11.84% | 27.79B | |
| -32.98% | 2.98B | |
| -15.97% | 2.52B | |
| +11.90% | 2.34B | |
| -1.11% | 1.91B | |
| -13.37% | 1.83B | |
| -7.78% | 1.39B | |
| -0.38% | 1.27B | |
| +13.51% | 1.12B |
GLYCOREX TRANSPLANTATION AB 
